| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.001 |